Dr. Reddy's Laboratories Ltd. Financials

NSE BSE

15:59 Jul 31

Dr. Reddy's Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1270.30

-21.80 (-1.69%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1270.30

-21.80 (-1.69%)
15:59 Jul 31

Quality

39/100
Medium Financial Strength

Valuation

41/100
Mid Valuation

Technical

53/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM 2025
Net Sales	21545.2	24669.7	28011.1	32643.9	33519.9
Operating Expenses +	17777.5	18320.7	20078	24096.8	24922.1
Raw Material	7796.1	7586.8	8889.2	10524.6	11169
Increase Decrease in Cost	-353.9	70.9	-680.5	-544.7	-563.3
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	3885.8	4646.6	5030.1	5580	5669.8
Miscellaneous Expenses	13416.9	12750.4	15637.4	18219.1	8646.6
Operating Profit	3767.7	6349	7933.1	8547.1	8597.8
Other Income	484.4	1055.5	894.3	1097.3	1270.1
Depreciation	1165.2	1250.2	1470	1703.7	1799.2
Interest	95.8	142.8	171.1	282.9	306
Profit before tax and exceptio..	2991.1	6011.5	7186.3	7657.8	7762.7
Exceptional Items	0	0	0	0	0
PBT	2991.1	6011.5	7186.3	7657.8	7762.7
Provision for Taxation	878.9	1541.2	1623.1	1954.3	1959.2
Net Profit	2112.2	4470.3	5563.2	5703.5	5726.7
NET Profit after MI	2182.5	4507.3	5577.9	5655.1	5680.8
EPS	131.21	271.47	335.22	67.79	133.58
Operating Profit Margin (%)	17.49	25.74	28.32	26.18	25.65
Net Profit Margin (%)	10.13	18.27	19.91	17.32	16.95

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	26.60	26.60	26.60	26.60	26.60
FII	25.30	25.80	26.80	27.50	27.70
MF	13.60	12.90	11.10	10.90	10.00
Others	24.20	24.20	25.10	24.80	25.30

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: